These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1094 related items for PubMed ID: 19633543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients.
    Carson SS, Kress JP, Rodgers JE, Vinayak A, Campbell-Bright S, Levitt J, Bourdet S, Ivanova A, Henderson AG, Pohlman A, Chang L, Rich PB, Hall J.
    Crit Care Med; 2006 May; 34(5):1326-32. PubMed ID: 16540958
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters.
    MacLaren R, Forrest LK, Kiser TH.
    Pharmacotherapy; 2007 Mar; 27(3):351-9. PubMed ID: 17316147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J, Donner A.
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [Abstract] [Full Text] [Related]

  • 10. Propofol associated with a shorter duration of mechanical ventilation than scheduled intermittent lorazepam: a database analysis using Project IMPACT.
    Fong JJ, Kanji S, Dasta JF, Garpestad E, Devlin JW.
    Ann Pharmacother; 2007 Dec; 41(12):1986-91. PubMed ID: 17956957
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.
    Venn M, Newman J, Grounds M.
    Intensive Care Med; 2003 Feb; 29(2):201-7. PubMed ID: 12594584
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tracheotomy does not affect reducing sedation requirements of patients in intensive care--a retrospective study.
    Veelo DP, Dongelmans DA, Binnekade JM, Korevaar JC, Vroom MB, Schultz MJ.
    Crit Care; 2006 Feb; 10(4):R99. PubMed ID: 16834768
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
    Gupta P, Whiteside W, Sabati A, Tesoro TM, Gossett JM, Tobias JD, Roth SJ.
    Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
    [Abstract] [Full Text] [Related]

  • 20. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit.
    Candiotti KA, Gan TJ, Young C, Bekker A, Sum-Ping ST, Kahn R, Lebowitz P, Littman JJ.
    Anesth Analg; 2011 Sep; 113(3):550-6. PubMed ID: 21596879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.